中国医疗前沿
中國醫療前沿
중국의료전연
CHINA HEALTHCARE INNOVATION
2013年
6期
81-82
,共2页
磁共振弥散成像%ADC%疗效
磁共振瀰散成像%ADC%療效
자공진미산성상%ADC%료효
DWI%ADC%Effect
目的探讨弥散成像在恶性肿瘤疗效评估中的研究价值.方法对35例拟诊恶性肿瘤患者,分别于治疗前、治疗开始后1个月分别行MR平扫、增强及弥散加权成像检查,测量治疗前、后不同时间点肿瘤最大径和ADC值,分析各疗效组治疗前后不同时间点肿瘤最大径和恶性肿瘤ADC值的动态变化趋势,对弥散加权成像在恶性肿瘤疗效评估进行探讨.结果 PR组治疗前、治疗后1个月ADC值分别为(0.93±0.09)×10-3mm2/s、(1.21±0.17)×10-3mm2/s,SD组治疗前、治疗后1个月ADC值分别为(0.93±0.09)×10-3mm2/s、(1.15±0.17)×10-3mm2/s.结论弥散成像对恶性肿瘤疗效可以进行早期评估.
目的探討瀰散成像在噁性腫瘤療效評估中的研究價值.方法對35例擬診噁性腫瘤患者,分彆于治療前、治療開始後1箇月分彆行MR平掃、增彊及瀰散加權成像檢查,測量治療前、後不同時間點腫瘤最大徑和ADC值,分析各療效組治療前後不同時間點腫瘤最大徑和噁性腫瘤ADC值的動態變化趨勢,對瀰散加權成像在噁性腫瘤療效評估進行探討.結果 PR組治療前、治療後1箇月ADC值分彆為(0.93±0.09)×10-3mm2/s、(1.21±0.17)×10-3mm2/s,SD組治療前、治療後1箇月ADC值分彆為(0.93±0.09)×10-3mm2/s、(1.15±0.17)×10-3mm2/s.結論瀰散成像對噁性腫瘤療效可以進行早期評估.
목적탐토미산성상재악성종류료효평고중적연구개치.방법대35례의진악성종류환자,분별우치료전、치료개시후1개월분별행MR평소、증강급미산가권성상검사,측량치료전、후불동시간점종류최대경화ADC치,분석각료효조치료전후불동시간점종류최대경화악성종류ADC치적동태변화추세,대미산가권성상재악성종류료효평고진행탐토.결과 PR조치료전、치료후1개월ADC치분별위(0.93±0.09)×10-3mm2/s、(1.21±0.17)×10-3mm2/s,SD조치료전、치료후1개월ADC치분별위(0.93±0.09)×10-3mm2/s、(1.15±0.17)×10-3mm2/s.결론미산성상대악성종류료효가이진행조기평고.
Objective To investigate the value of diffusion-weighted imaging in evaluating the curative effect of malignant tumor. Methods 35 cases of the patients were malignant tumors, prior to beginning treatment, 1 months after treatment were performed MR plain scan, enhanced and diffusion weighted imaging, measured before treatment, at different time points after the maximal tumor diameter and ADC value, analysis of the dynamic change trend of different time points of maximum tumor diameter and tumor ADC the effect of group therapy, carries on the discussion to the diffusion-weighted imaging in malignant tumor curative effect evaluation. Results PR group before treatment, 1 months after treatment the ADC values were (0.93±0.09)×10-3mm2/s, (1.21±0.17)×10-3mm2/s, SD groups before treatment, 1 months after treatment the ADC values were (0.93±0.0)×10-3mm2/s, (1.15±0.17)×10-3mm2/s. Conclusion Diffusion-weighted imaging for early evaluation of curative effect of malignant tumor.